Early sofosbuvir-ledipasvir treatment for acute HCV infection induced severe immune thrombocytopenia – a case report

Abstract : Background: Hepatitis C virus (HCV) infection is a recognised cause of secondary immune thrombocytopenia (ITP). While its incidence has been largely described during chronic HCV infection, only one case of ITP secondary to acute HCV infection has been reported at this time. Case presentation: We report herein the case of severe ITP secondary to an acute HCV genotype 1a reinfection in a human immunodeficiency virus (HIV)-negative man having sex with men who had been cured several years before of a previous acute genotype 4d HCV infection. After an unsuccessful standard therapy with two courses of intravenous immunoglobulin (at 1 g/kg daily for 2 days) associated with methylprednisolone 1 mg/kg daily, antiviral treatment with sofosbuvir-ledipasvir rapidly achieved virological response and normalised the platelet count. Conclusions: As a direct effect of HCV on megakaryocytes could be the predominant cause of ITP during acute infection, early antiviral treatment may be beneficial in this case.
Complete list of metadatas

Cited literature [15 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02043152
Contributor : Myriam Bodescot <>
Submitted on : Wednesday, February 20, 2019 - 5:34:15 PM
Last modification on : Thursday, November 21, 2019 - 2:05:55 AM

File

12879_2018_Article_3597.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Vincent Alcazer, Patrick Miailhes, Christophe Ramière, Caroline Charre, Laurent Cotte. Early sofosbuvir-ledipasvir treatment for acute HCV infection induced severe immune thrombocytopenia – a case report. BMC Infectious Diseases, BioMed Central, 2018, 18 (1), pp.682. ⟨10.1186/s12879-018-3597-4⟩. ⟨inserm-02043152⟩

Share

Metrics

Record views

116

Files downloads

152